The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CHECK CAP LTD | SHS | M2361E112 | 351 | 177,381 | SH | SOLE | 177,381 | 0 | 0 | ||
| NEOGENOMICS INC | COM NEW | 64049M209 | 123,300 | 15,000,000 | SH | SOLE | 15,000,000 | 0 | 0 | ||
| SOLAREDGE TECHNOLOGIES INC | COM | 83417M104 | 7,006 | 406,650 | SH | SOLE | 406,650 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 726 | 47,945 | SH | SOLE | 53,646 | 0 | 0 | ||
| TPI Composites Inc | COM | 87266J104 | 60,438 | 2,842,829 | SH | SOLE | 2,842,829 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 2,013 | 264,550 | SH | SOLE | 264,550 | 0 | 0 | ||